Duopharma Biotech Bhd (7148) — Net Asset Quality Index
Duopharma Biotech Bhd (7148) has a Net Asset Quality Index of 52.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of RM1.45 Billion minus total liabilities of RM689.10 Million yields net assets of RM757.35 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read 7148 liabilities breakdown for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Duopharma Biotech Bhd Net Asset Quality Index Over Time (2006–2025)
This chart shows how Duopharma Biotech Bhd's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the index stands at 52.4%, representing net assets of RM757.35 Million against total assets of RM1.45 Billion MYR. For live market cap and overall valuation, see Duopharma Biotech Bhd (7148) total market value.
Annual Net Asset Quality Index for Duopharma Biotech Bhd (2006–2025)
The table below presents the year-by-year Net Asset Quality Index for Duopharma Biotech Bhd from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Duopharma Biotech Bhd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (MYR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 52.3% | RM757.62 Million | RM1.45 Billion | RM690.68 Million | ▲ +0.8 pp |
| 2024 | 51.5% | RM709.15 Million | RM1.38 Billion | RM667.85 Million | ▲ +0.4 pp |
| 2023 | 51.1% | RM687.12 Million | RM1.35 Billion | RM658.01 Million | ▼ -2.5 pp |
| 2022 | 53.6% | RM655.22 Million | RM1.22 Billion | RM566.70 Million | ▲ +0.0 pp |
| 2021 | 53.6% | RM624.00 Million | RM1.16 Billion | RM540.13 Million | ▼ -7.2 pp |
| 2020 | 60.8% | RM643.82 Million | RM1.06 Billion | RM414.61 Million | ▲ +3.2 pp |
| 2019 | 57.6% | RM529.75 Million | RM919.80 Million | RM390.05 Million | ▲ +0.1 pp |
| 2018 | 57.5% | RM481.04 Million | RM836.38 Million | RM355.34 Million | ▼ -10.5 pp |
| 2017 | 68.0% | RM479.87 Million | RM705.24 Million | RM225.38 Million | ▼ -0.7 pp |
| 2016 | 68.7% | RM454.52 Million | RM661.46 Million | RM206.95 Million | ▼ -2.3 pp |
| 2015 | 71.0% | RM449.72 Million | RM633.45 Million | RM183.73 Million | ▼ -16.0 pp |
| 2014 | 87.0% | RM193.63 Million | RM222.48 Million | RM28.85 Million | ▼ -1.8 pp |
| 2013 | 88.8% | RM182.65 Million | RM205.65 Million | RM23.00 Million | ▲ +2.7 pp |
| 2012 | 86.1% | RM170.50 Million | RM198.03 Million | RM27.53 Million | ▲ +2.8 pp |
| 2011 | 83.3% | RM164.44 Million | RM197.52 Million | RM33.08 Million | ▲ +2.9 pp |
| 2010 | 80.3% | RM157.87 Million | RM196.48 Million | RM38.61 Million | ▼ -2.0 pp |
| 2009 | 82.3% | RM142.74 Million | RM173.36 Million | RM30.63 Million | ▼ -4.5 pp |
| 2008 | 86.8% | RM130.55 Million | RM150.38 Million | RM19.83 Million | ▼ -2.9 pp |
| 2007 | 89.7% | RM114.21 Million | RM127.33 Million | RM13.12 Million | ▼ -1.8 pp |
| 2006 | 91.5% | RM145.43 Million | RM159.01 Million | RM13.58 Million | — |